Pituitary Society is ranked #3 of 21 disease & disorders organizations in Los Angeles, CA, with an America's Best Score of 87 out of 100, based on its 2025 Form 990.
Pituitary Society is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G43). Contributions are tax-deductible.
8700 Beverly Blvd 2051, Los Angeles, CA 90048-1804
Among the 28 scored disease & disorders organizations in Los Angeles, Pituitary Society holds 59.3 months of operating reserves (peer median 13.4 months), runs a typical yearly surplus of 42.0% (peers: surplus of 3.7%), and has grown spending 32.7% a year (peers: grown spending 9.7% a year).
In fiscal year 2025 it reported $753,709 in revenue and $483,415 in expenses, with contributions making up 92.1% of revenue.
Our mission is to provide scientists, clinicians and trainees with the most up-to-date, reliable research and education on the biology of the pituitary gland and the causes, diagnosis and treatment of pituitary gland related diseases, in order to improve patient care and to provide a uniquely international forum for professional growth and scientific exchange.
Largest programs · fiscal year 2025
Gropro conferencethe growth hormone (gh)/ prolactin (prl) family in biology & disease conference (gropro) was held August 11-15, 2024, in stirling, scotland. This conference used to be associated with federation of American societies for experimental biology (faseb) and before that with the gordon conferences. So, it has long history, over 2 decades. This iteration of the conference was held in as… Read more
Gropro conferencethe growth hormone (gh)/ prolactin (prl) family in biology & disease conference (gropro) was held August 11-15, 2024, in stirling, scotland. This conference used to be associated with federation of American societies for experimental biology (faseb) and before that with the gordon conferences. So, it has long history, over 2 decades. This iteration of the conference was held in association with the Pituitary Society. This conference was held in europe for the first time with over 90 scientists, physicians, and trainees in attendance.the scientific theme of this conference is to improve our understanding of the regulation and action of gh and prl and their specific receptors as well as their role in disease promotion or prevention.
$100,100 spent · 77.7% of program spending
Preceptorship course for fellows-in-trainingthis course, held in January 2025, was the seventh since its inception. The course was attended by approximately 225 fellows-in-training. Fellows were required to submit an interesting pituitary case to attend the course. Cases were reviewed by faculty and four-to-six were selected to be presented by the fellows during the case discussion. Faculty record… Read more
Preceptorship course for fellows-in-trainingthis course, held in January 2025, was the seventh since its inception. The course was attended by approximately 225 fellows-in-training. Fellows were required to submit an interesting pituitary case to attend the course. Cases were reviewed by faculty and four-to-six were selected to be presented by the fellows during the case discussion. Faculty recorded presentations on all pituitary pathology were viewed by the fellows prior to the live webinars to allow for more interactive learning.over the last decade, many endocrinology fellowship programs reduced the training requirements from 3 years to 2 years to be eligible for board certification. In parallel, diabetes and obesity incidence and prevalence increased significantly, limiting clinical experiences on other rarer, nevertheless severe and potentially lethal diseases, such as pituitary disorders. Therefore, this course taught by leading international experts, addressed some of these issues by reviewing for trainees advancements in diagnosis and treatment of hypopituitarism, growth hormone deficiency, cushing's syndrome and acromegaly as well as management of pituitary disease in the post-covid era.
$18,648 spent · 14.5% of program spending
Pituitary Society consensus guideline for pituitary incidentalomas (published guideline)within the constraints of limited evidence-based reports, this Pituitary Society consensus summarizes the epidemiology and natural history, diagnostic work-up, and treatment options for patients with pituitary incidentalomas. We distinguish between pituitary adenomas and other types of incidentalomas and partic… Read more
Pituitary Society consensus guideline for pituitary incidentalomas (published guideline)within the constraints of limited evidence-based reports, this Pituitary Society consensus summarizes the epidemiology and natural history, diagnostic work-up, and treatment options for patients with pituitary incidentalomas. We distinguish between pituitary adenomas and other types of incidentalomas and particularly distinguish between microadenomas and macroadenomas given the lower likelihood of the latter to be a truly incidental finding.the guidelines were published in nature reviews endocrinology.
$10,000 spent · 7.8% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 27¢ went to programs, 73¢ to management and 0¢ to fundraising.
Programs $128,748
Management $354,667
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Operating reserves (reduced: more than 3 years of cash)
59.3 mo; 67.8 mo in cash
15.6 / 25
Financial balance (median margin)
+42.0%
19.7 / 20
Transparency
4 full 990s, latest TY2025
20 / 20
Program growth
+32.7% / yr
15 / 15
Track record
22 years
8.8 / 10
Debt load
22.4% of assets
7.5 / 10
Total
86.6 → 87
Spending on programs Not scored; America's Best needs 65%+
27%
Below
Compared with Los Angeles peers
Measure
This organization
Peer median
Operating reserves
59.3 mo
13.4 mo
Typical margin
+42.0%
+3.7%
Spending growth
+32.7% / yr
+9.7% / yr
Debt load
22.4%
2.4%
Peers: the 28 Los Angeles disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$753,709Fiscal year 2025
Expenses$483,415Fiscal year 2025
Total assets$3,079,505Fiscal year 2025
Total liabilities$689,239Fiscal year 2025
Fiscal year ending June2025
Revenue$753,709
Expenses$483,415
Net income$270,294
Net assets$2,390,266
Notable sources of revenue
Percent of total revenue
Contributions
$694,053
92.1%
Program services
$2,230
0.3%
Investment income
$56,433
7.5%
Other (net)
$993
0.1%
Assets / debt
Total assets
$3,079,505
Total liabilities
$689,239
Net assets
$2,390,266
Compensation
Not in our extract for this year.
Fiscal year ending June2024
Revenue$551,129
Expenses$488,822
Net income$62,307
Net assets$2,119,972
Notable sources of revenue
Percent of total revenue
Contributions
$413,854
75.1%
Program services
$66,725
12.1%
Investment income
$63,243
11.5%
Other (net)
$7,307
1.3%
Assets / debt
Total assets
$2,128,717
Total liabilities
$8,745
Net assets
$2,119,972
Compensation
Not in our extract for this year.
Fiscal year ending June2023
Revenue$798,095
Expenses$549,749
Net income$248,346
Net assets$2,057,665
Notable sources of revenue
Percent of total revenue
Contributions
$433,264
54.3%
Program services
$327,460
41.0%
Investment income
$27,475
3.4%
Other (net)
$9,896
1.2%
Assets / debt
Total assets
$2,298,432
Total liabilities
$240,767
Net assets
$2,057,665
Compensation
Officers and key employees
$0
Share of expenses
0.0%
Fiscal year ending June2022
Revenue$287,129
Expenses$206,827
Net income$80,302
Net assets$1,809,319
Notable sources of revenue
Percent of total revenue
Contributions
$22,450
7.8%
Program services
$262,450
91.4%
Investment income
$137
0.0%
Other (net)
$2,092
0.7%
Assets / debt
Total assets
$1,840,975
Total liabilities
$31,656
Net assets
$1,809,319
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?